Arsenic cancer risk still high decades later
January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.
Not enough evidence for bladder cancer screening
August 16, 2011 — NEW YORK (Reuters Health) - There is not enough evidence to support routine screening tests for bladder cancer, according to new U.S. recommendations.
EU agency calls for new warnings on Takeda's Actos
July 21, 2011 — LONDON (Reuters) - Takeda Pharmaceutical's diabetes pill Actos should carry new warnings about its possible link to bladder cancer, Europe's drug regulator said on Thursday, following a safety review of the medicine.
Select news items provided by Reuters Health